HopeStage
Back to all studies
CompletedNCT00271219

Methadone or buprenorphine treatment during pregnancy

About this titleRead the official source — NCT00271219
Medication studyAges 18–41Multiple countriesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 41 years.

Listed locations
Baltimore and 7 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJuly 2005
Recruitment status
Completed
Enrollment listed in the registry
175
Sponsor
Johns Hopkins University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, Canada, Austria
Age range
From 18 Years to 41 Years
Official registry ID
NCT00271219
Official title
Show the full official title

Maternal Opioid Treatment: Human Experimental Research

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Baltimore, United States · Detroit, United States · Philadelphia, United States

5 more locations
  • Providence, United States
  • Nashville, United States
  • Burlington, United States
  • Vienna, Austria
  • Toronto, Canada

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Johns Hopkins University, a university.

Did this study involve medication?

Yes. The study involved medication, including Methadone and Buprenorphine.

Who was this study for?

Listed age limits: 18 years to 41 years.

Want to explore more studies?

Explore studies